Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q3 2019 13F Holders as of 30 Sep 2019

Holder snapshot 7 signals
Share change
+7,315,198
Put/Call ratio
98%
SEC-reported price per share
$9.62
Number of holders
105
Value change
+$83,519,427
Number of buys
63
Open additional details 1 more signal available
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,658,403

Security key

48576U106

Report period

Q3 2019

Institutions

105

Top holders

10

Ownership snapshot

Top reported holders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Jun 2019
13F Lead comparable stake: 37% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 37%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 37%
Consonance Capital Management LP 26%
Palo Alto Investors LP 23%
BlackRock Finance, Inc. 20%
ORBIMED ADVISORS LLC 14%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
37%
$50,547,000
8,438,412 shares
30 Jun 2019
Consonance Capital Management LP
13F
Company
13F
26%
$34,761,000
5,803,227 shares
30 Jun 2019
Palo Alto Investors LP
13F
Company
13F
23%
$31,521,000
5,262,263 shares
30 Jun 2019
BlackRock Finance, Inc.
13F
Company
13F
20%
$27,112,000
4,526,508 shares
30 Jun 2019
ORBIMED ADVISORS LLC
13F
Company
13F
14%
$18,859,000
3,148,475 shares
30 Jun 2019
VANGUARD GROUP INC
13F
Company
13F
13%
$17,874,000
2,983,862 shares
30 Jun 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
105
Shares
58,481,490
Rows available
105
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2019 vs Q4 2025 Across Filers

Q4 2025 holders
0
Q3 2019 holders
105
Holder diff
105
Investor Q4 2025 Shares Q3 2019 Shares Share Diff Share Chg % Q4 2025 value Q3 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .